Empatica launches WellPD, an FDA-cleared Parkinson’s monitoring device for home use

BOSTON, Oct. 28, 2026 /PRNewswire/ -- Empatica, a leader in digital biomarker development and clinical-grade wearable technology, today announced WellPD, an FDA-cleared and CE-marked wearable device and companion app for people with Parkinson's to monitor their symptoms at home.


WellPD’s wrist-worn device tracks motor symptoms, including tremor, dyskinesia, and bradykinesia, as well as sleep and activity. The companion app brings these measurements together with daily summaries, helping people understand how their symptoms fluctuate, recognize changes around medication doses, and discuss these patterns with their care teams.

“Empatica was founded on the belief that technology should be friendly, caring, and more human,” said Matteo Lai, CEO and co-founder of Empatica. “With WellPD, we’re bringing years of work in wearable technology and Parkinson’s research into a comfortable device that can be worn at home, giving people with Parkinson’s and their families access to daily health information they can understand and share with their care teams.”

Sign up for Blog Updates